Director/PDMR Shareholding

Cambridge Nutritional Sciences PLC

30 January 2025

 

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

Director/PDMR Shareholding

CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 97,500 ordinary shares of 4 pence each in the Company ("Ordinary Shares") on 29 January 2025, at a price of 3.668 pence each.

A summary of Carolyn Rand's resultant holdings is below:

Director	Board Position	Number of Ordinary Shares acquired	Total beneficial holding of Ordinary Shares following this acquisition
			Number of Ordinary Shares	Approximate % of Company's issued share capital
Carolyn Rand	Non-Executive Chair	97,500	97,500	0.04%

Contacts: 

Cambridge Nutritional Sciences plc			www.cnsplc.com
Carolyn Rand, Non-Executive Chair
James Cooper, Interim Chief Executive
Cavendish Capital Markets Limited			Tel: [phone]
Geoff Nash / Edward Whiley (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Carolyn Rand
2	Reason for the notification
a)	Position/status	Non-Executive Chair
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Cambridge Nutritional Sciences plc
b)	LEI	2138007U9P4BTZTYIR92
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 4 pence each ISIN: GB00B1VCP282
b)	Nature of the transaction	Ordinary Shares purchased
c)	Price(s) and volume(s)	Price(s) Volume(s) 3.668 pence 97,500
d)	Aggregated information -Aggregated volume - Price	See above
e)	Date of the transaction	29.01.2025
f)	Place of the transaction	London Stock Exchange

 

END